These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39233335)

  • 1. ALKBH5-mediated m
    Xu R; Yang E; Liang H; Luo S; Liu Y; Khoong Y; Li H; Huang X; Zhao Y; Zan T
    Clin Transl Med; 2024 Sep; 14(9):e70016. PubMed ID: 39233335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction.
    Yang K; Zhao Y; Hu J; Gao R; Shi J; Wei X; Chen J; Hu K; Sun A; Ge J
    J Adv Res; 2024 Jul; 61():193-209. PubMed ID: 37689242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
    Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
    J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.
    Wang J; Yang Y; Sun F; Luo Y; Yang Y; Li J; Hu W; Tao H; Lu C; Yang JJ
    Pharmacol Res; 2023 Jan; 187():106608. PubMed ID: 36566000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape.
    Meng Y; Shu Z; Wang X; Hong L; Wang B; Jiang J; He K; Cao Q; Shi F; Wang H; Gong L; Diao H
    Mol Cancer Res; 2024 Jul; 22(7):642-655. PubMed ID: 38546386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALKBH5-mediated m
    Lei Y; Zhan E; Chen C; Hu Y; Lv Z; He Q; Wang X; Li X; Zhang F
    Cell Biosci; 2024 Jun; 14(1):79. PubMed ID: 38877576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKBH5-mediated m
    Huang X; Zhao Y; Liu D; Gu S; Liu Y; Khoong Y; Luo S; Zhang Z; Xia W; Wang M; Liang H; Li M; Li Q; Zan T
    Inflamm Regen; 2023 Jul; 43(1):36. PubMed ID: 37452367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.
    Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D
    Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine demethylase ALKBH5 homologous protein protects against cerebral I/R injury though suppressing SNHG3-mediated neural PANoptosis: Involvement of m6A-related macromolecules in the diseases of nervous system.
    Qiu Y; Fan Y; Huang G; Liu J
    Int J Biol Macromol; 2024 Aug; 274(Pt 2):133815. PubMed ID: 38996894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
    Zhang L; Su X
    Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM4C represses liver fibrosis by regulating H3K9me3 methylation of ALKBH5 and m6A methylation of snail1 mRNA.
    Zhou HY; Wang BQ; Chen MX; Wang YF; Jiang YF; Ma J
    J Dig Dis; 2024 May; 25(5):298-309. PubMed ID: 38938016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.